{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:45:25Z","timestamp":1792028725038,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T00:00:00Z","timestamp":1358985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00702-013-0977-1","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T12:11:50Z","timestamp":1358943110000},"page":"1053-1060","source":"Crossref","is-referenced-by-count":7,"title":["Impact of subcortical white matter lesions on dopamine transporter SPECT"],"prefix":"10.1007","volume":"120","author":[{"given":"Elisabeth","family":"Funke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kupsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Buchert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,24]]},"reference":[{"issue":"6","key":"977_CR1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.parkreldis.2012.03.017","volume":"18","author":"A Antonini","year":"2012","unstructured":"Antonini A, Vitale C, Barone P et al (2012) The relationship between cerebral vascular disease and parkinsonism: the VADO study. Parkinsonism Relat Disord 18(6):775\u2013780","journal-title":"Parkinsonism Relat Disord"},{"issue":"16","key":"977_CR2","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1212\/WNL.0b013e3181a18809","volume":"72","author":"PG Bain","year":"2009","unstructured":"Bain PG (2009) Dystonic tremor presenting as parkinsonism: long-term follow-up of SWEDDs. Neurology 72(16):1443\u20131445","journal-title":"Neurology"},{"issue":"6","key":"977_CR3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1600-0404.1996.tb00015.x","volume":"93","author":"H Boecker","year":"1996","unstructured":"Boecker H, Weindl A, Leenders K et al (1996) Secondary parkinsonism due to focal substantia nigra lesions: a PET study with [18F]FDG and [18F]fluorodopa. Acta Neurol Scand 93(6):387\u2013392","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"977_CR4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrneurol.2011.21","volume":"7","author":"NI Bohnen","year":"2011","unstructured":"Bohnen NI, Albin RL (2011) White matter lesions in Parkinson disease. Nat Rev Neurol 7(4):229\u2013236","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"977_CR5","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/WNL.52.6.1214","volume":"52","author":"JH Bower","year":"1999","unstructured":"Bower JH, Maraganore DM, McDonnell SK et al (1999) Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976\u20131990. Neurology 52(6):1214\u20131220","journal-title":"Neurology"},{"key":"977_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-3-7091-6842-4_2","volume":"50","author":"T Brucke","year":"1997","unstructured":"Brucke T, Asenbaum S, Pirker W et al (1997) Measurement of the dopaminergic degeneration in Parkinson\u2019s disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. J Neural Transm Suppl 50:9\u201324","journal-title":"J Neural Transm Suppl"},{"issue":"6","key":"977_CR7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1600-0404.1992.tb05492.x","volume":"86","author":"CM Chang","year":"1992","unstructured":"Chang CM, Yu YL, Ng HK et al (1992) Vascular pseudoparkinsonism. Acta Neurol Scand 86(6):588\u2013592","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"977_CR8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/brain\/52.1.23","volume":"52","author":"M Critchley","year":"1929","unstructured":"Critchley M (1929) Arteriosclerotic Parkinsonism. Brain 52(1):23\u201383","journal-title":"Brain"},{"issue":"1","key":"977_CR9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jnnp.62.1.10","volume":"62","author":"MC Rijk de","year":"1997","unstructured":"de Rijk MC, Tzourio C, Breteler MM et al (1997) Prevalence of parkinsonism and Parkinson\u2019s disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 62(1):10\u201315","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"977_CR10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1034\/j.1600-0404.2001.104002063.x","volume":"104","author":"M Demirkiran","year":"2001","unstructured":"Demirkiran M, Bozdemir H, Sarica Y (2001) Vascular parkinsonism: a distinct, heterogeneous clinical entity. Acta Neurol Scand 104(2):63\u201367","journal-title":"Acta Neurol Scand"},{"key":"977_CR11","unstructured":"Ebersbach G, Poewe W (2006) Vascular parkinsonian syndrome. Nervenarzt 77(2):139\u2013144, 146\u2013137"},{"key":"977_CR12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/978-3-211-45295-0_63","volume":"70","author":"S Fahn","year":"2006","unstructured":"Fahn S (2006) A new look at levodopa based on the ELLDOPA study. J Neural Transm Suppl 70:419\u2013426","journal-title":"J Neural Transm Suppl"},{"issue":"1","key":"977_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000048607","volume":"21","author":"T Foltynie","year":"2002","unstructured":"Foltynie T, Barker R, Brayne C (2002) Vascular parkinsonism: a review of the precision and frequency of the diagnosis. Neuroepidemiology 21(1):1\u20137","journal-title":"Neuroepidemiology"},{"issue":"3","key":"977_CR14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mds.10092","volume":"17","author":"W Gerschlager","year":"2002","unstructured":"Gerschlager W, Bencsits G, Pirker W et al (2002) [123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson\u2019s disease. Mov Disord 17(3):518\u2013523","journal-title":"Mov Disord"},{"issue":"5","key":"977_CR15","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/NEN.0b013e3181d88e63","volume":"69","author":"E Ghebremedhin","year":"2010","unstructured":"Ghebremedhin E, Rosenberger A, Rub U et al (2010) Inverse relationship between cerebrovascular lesions and severity of Lewy body pathology in patients with Lewy body diseases. J Neuropathol Exp Neurol 69(5):442\u2013448","journal-title":"J Neuropathol Exp Neurol"},{"issue":"9","key":"977_CR16","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00702-005-0401-6","volume":"113","author":"S Hesse","year":"2006","unstructured":"Hesse S, Oehlwein C, Barthel H et al (2006) Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome. J Neural Transm 113(9):1177\u20131190","journal-title":"J Neural Transm"},{"issue":"3","key":"977_CR17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"977_CR18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mds.22937","volume":"25","author":"S Kalra","year":"2010","unstructured":"Kalra S, Grosset DG, Benamer HT (2010) Differentiating vascular parkinsonism from idiopathic Parkinson\u2019s disease: a systematic review. Mov Disord 25(2):149\u2013156","journal-title":"Mov Disord"},{"issue":"10","key":"977_CR19","first-page":"1688","volume":"45","author":"M Lorberboym","year":"2004","unstructured":"Lorberboym M, Djaldetti R, Melamed E et al (2004) 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism. J Nucl Med 45(10):1688\u20131693","journal-title":"J Nucl Med"},{"issue":"1","key":"977_CR20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1212\/WNL.46.1.231","volume":"46","author":"KL Marek","year":"1996","unstructured":"Marek KL, Seibyl JP, Zoghbi SS et al (1996) [123I] beta-CIT\/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson\u2019s disease. Neurology 46(1):231\u2013237","journal-title":"Neurology"},{"issue":"Suppl 3","key":"977_CR21","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1002\/ana.10486","volume":"53","author":"K Marek","year":"2003","unstructured":"Marek K, Jennings D, Seibyl J (2003) Dopamine agonists and Parkinson\u2019s disease progression: what can we learn from neuroimaging studies. Ann Neurol 53(Suppl 3):S160\u2013S166 (discussion S166\u2013S169)","journal-title":"Ann Neurol"},{"issue":"4","key":"977_CR22","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/mds.870100408","volume":"10","author":"MH Mark","year":"1995","unstructured":"Mark MH, Sage JI, Walters AS et al (1995) Binswanger\u2019s disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases. Mov Disord 10(4):450\u2013454","journal-title":"Mov Disord"},{"issue":"3","key":"977_CR23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/01.STR.23.3.328","volume":"23","author":"M Nakane","year":"1992","unstructured":"Nakane M, Teraoka A, Asato R et al (1992) Degeneration of the ipsilateral substantia nigra following cerebral infarction in the striatum. Stroke 23(3):328\u2013332","journal-title":"Stroke"},{"issue":"4","key":"977_CR24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/01616412.1990.11739949","volume":"12","author":"H Nakayama","year":"1990","unstructured":"Nakayama H, Tamura A, Kanazawa I et al (1990) Time-sequential change of amino acid neurotransmitters\u2014GABA, aspartate and glutamate\u2014in the rat basal ganglia following middle cerebral artery occlusion. Neurol Res 12(4):231\u2013235","journal-title":"Neurol Res"},{"issue":"10\u201311","key":"977_CR25","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00702-004-0192-1","volume":"111","author":"C Peralta","year":"2004","unstructured":"Peralta C, Werner P, Holl B et al (2004) Parkinsonism following striatal infarcts: incidence in a prospective stroke unit cohort. J Neural Transm 111(10\u201311):1473\u20131483","journal-title":"J Neural Transm"},{"issue":"2","key":"977_CR26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archneur.1995.00540260097023","volume":"52","author":"P Piccini","year":"1995","unstructured":"Piccini P, Pavese N, Canapicchi R et al (1995) White matter hyperintensities in Parkinson\u2019s disease. Clinical correlations. Arch Neurol 52(2):191\u2013194","journal-title":"Arch Neurol"},{"issue":"5","key":"977_CR27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00702-004-0208-x","volume":"112","author":"M Plotkin","year":"2005","unstructured":"Plotkin M, Amthauer H, Klaffke S et al (2005a) Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. J Neural Transm 112(5):677\u2013692","journal-title":"J Neural Transm"},{"issue":"10","key":"977_CR28","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00702-005-0278-4","volume":"112","author":"M Plotkin","year":"2005","unstructured":"Plotkin M, Amthauer H, Quill S et al (2005b) Imaging of dopamine transporters and D2 receptors in vascular parkinsonism: a report of four cases. J Neural Transm 112(10):1355\u20131361","journal-title":"J Neural Transm"},{"issue":"11","key":"977_CR29","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/mds.21085","volume":"21","author":"C Reitz","year":"2006","unstructured":"Reitz C, Trenkwalder C, Kretzschmar K et al (2006) Relation of cerebral small-vessel disease and brain atrophy to mild Parkinsonism in the elderly. Mov Disord 21(11):1914\u20131919","journal-title":"Mov Disord"},{"issue":"1","key":"977_CR30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/mds.22893","volume":"25","author":"G Santangelo","year":"2010","unstructured":"Santangelo G, Vitale C, Trojano L et al (2010) Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions. Mov Disord 25(1):50\u201356","journal-title":"Mov Disord"},{"issue":"4","key":"977_CR31","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ana.410380407","volume":"38","author":"JP Seibyl","year":"1995","unstructured":"Seibyl JP, Marek KL, Quinlan D et al (1995) Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson\u2019s disease. Ann Neurol 38(4):589\u2013598","journal-title":"Ann Neurol"},{"issue":"12","key":"977_CR32","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00415-011-6076-z","volume":"258","author":"F Sixel-Doring","year":"2011","unstructured":"Sixel-Doring F, Liepe K, Mollenhauer B et al (2011) The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases. J Neurol 258(12):2147\u20132154","journal-title":"J Neurol"},{"issue":"2","key":"977_CR33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ageing\/afi025","volume":"34","author":"B Thanvi","year":"2005","unstructured":"Thanvi B, Lo N, Robinson T (2005) Vascular parkinsonism\u2014an important cause of parkinsonism in older people. Age Ageing 34(2):114\u2013119","journal-title":"Age Ageing"},{"issue":"1","key":"977_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mds.870020101","volume":"2","author":"PD Thompson","year":"1987","unstructured":"Thompson PD, Marsden CD (1987) Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger\u2019s disease. Mov Disord 2(1):1\u20138","journal-title":"Mov Disord"},{"issue":"1","key":"977_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000050748","volume":"46","author":"H Tohgi","year":"2001","unstructured":"Tohgi H, Takahashi S, Abe T et al (2001) Symptomatic characteristics of parkinsonism and the width of substantia nigra pars compacta on MRI according to ischemic changes in the putamen and cerebral white matter: implications for the diagnosis of vascular parkinsonism. Eur Neurol 46(1):1\u201310","journal-title":"Eur Neurol"},{"issue":"10","key":"977_CR36","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archneur.1995.00540340109020","volume":"52","author":"C Trenkwalder","year":"1995","unstructured":"Trenkwalder C, Schwarz J, Gebhard J et al (1995) Starnberg trial on epidemiology of Parkinsonism and hypertension in the elderly. Prevalence of Parkinson\u2019s disease and related disorders assessed by a door-to-door survey of inhabitants older than 65\u00a0years. Arch Neurol 52(10):1017\u20131022","journal-title":"Arch Neurol"},{"issue":"3","key":"977_CR37","first-page":"408","volume":"42","author":"KY Tzen","year":"2001","unstructured":"Tzen KY, Lu CS, Yen TC et al (2001) Differential diagnosis of Parkinson\u2019s disease and vascular parkinsonism by (99m)Tc-TRODAT-1. J Nucl Med 42(3):408\u2013413","journal-title":"J Nucl Med"},{"issue":"1","key":"977_CR38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/mds.870130119","volume":"13","author":"M Zagten van","year":"1998","unstructured":"van Zagten M, Lodder J, Kessels F (1998) Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions. Mov Disord 13(1):89\u201395","journal-title":"Mov Disord"},{"issue":"5","key":"977_CR39","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000115640","volume":"59","author":"AM Vlaar","year":"2008","unstructured":"Vlaar AM, de Nijs T, Kessels AG et al (2008) Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes. Eur Neurol 59(5):258\u2013266","journal-title":"Eur Neurol"},{"issue":"1","key":"977_CR40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.10609","volume":"54","author":"AL Whone","year":"2003","unstructured":"Whone AL, Watts RL, Stoessl AJ et al (2003) Slower progression of Parkinson\u2019s disease with ropinirole versus levodopa: the REAL-PET study. Ann Neurol 54(1):93\u2013101","journal-title":"Ann Neurol"},{"issue":"1","key":"977_CR41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archneur.56.1.98","volume":"56","author":"J Winikates","year":"1999","unstructured":"Winikates J, Jankovic J (1999) Clinical correlates of vascular parkinsonism. Arch Neurol 56(1):98\u2013102","journal-title":"Arch Neurol"},{"issue":"1","key":"977_CR42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nic.2009.08.006","volume":"20","author":"JC Zijlmans","year":"2010","unstructured":"Zijlmans JC (2010) The role of imaging in the diagnosis of vascular parkinsonism. Neuroimaging Clin N Am 20(1):69\u201376","journal-title":"Neuroimaging Clin N Am"},{"issue":"12","key":"977_CR43","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1212\/WNL.45.12.2183","volume":"45","author":"JC Zijlmans","year":"1995","unstructured":"Zijlmans JC, Thijssen HO, Vogels OJ et al (1995) MRI in patients with suspected vascular parkinsonism. Neurology 45(12):2183\u20132188","journal-title":"Neurology"},{"issue":"6","key":"977_CR44","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/mds.20083","volume":"19","author":"JC Zijlmans","year":"2004","unstructured":"Zijlmans JC, Daniel SE, Hughes AJ et al (2004) Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 19(6):630\u2013640","journal-title":"Mov Disord"},{"issue":"9","key":"977_CR45","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/mds.21479","volume":"22","author":"J Zijlmans","year":"2007","unstructured":"Zijlmans J, Evans A, Fontes F et al (2007) [123I] FP-CIT spect study in vascular parkinsonism and Parkinson\u2019s disease. Mov Disord 22(9):1278\u20131285","journal-title":"Mov Disord"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-013-0977-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-013-0977-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-013-0977-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:30:23Z","timestamp":1559089823000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-013-0977-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,24]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["977"],"URL":"https:\/\/doi.org\/10.1007\/s00702-013-0977-1","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,24]]}}}